Company
OSSFILA Technology Limited is a Hong Kong-based startup company specialized in the R&D and manufacture of novel 3D printing material and 3D printed bone implants. Founded by three affiliates from the University of Hong Kong in 2018, OSSFILA aims to resolve the supply shortage of donor bone implants. The 3D-printing product composition will be based on a novel copolymer which promote superior biocompatibility while maintaining similar mechanical strength and durability of a normal bone compared to current alternatives. OSSFILA 3D-printing material and 3D-printed bone implants will offer a safe, effective and patient-specific solution for patients in need.
Our team consists of experienced scientists with post-graduate degrees specialized in biomaterials, medical engineering and clinical developments. We also have strong industrial and university collaborations to leverage our expertise to bring innovations and facilitate researchers and physicians in the orthopaedics field.
Description
Filaments which is made out of Hydroxyapatite (HA)-coated Polymethyl Methacrylate (PMMA) Nano-particles for research use by clinician-scientists and they will provide service as 3D-printed customizable orthopaedic implants for clinical and veterinarian application, using the polymer filaments.
